Inhibitory effect of reinioside C on vascular smooth muscle cells proliferation induced by angiotensin II via inhibiting NADPH oxidase-ROS-ERK1/2-NF- B-AP-1 pathway

Pharmazie

Volumn 69, Issue 9, 2014, Pages 698-703

  Hong, Dan ^a   Bai, Yong Ping ^a   Shi, Rui Zheng ^a   Tan, Gui Shan ^b   Hu, Chang Ping ^b   Zhang, Guo Gang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; DIPHENYLIODONIUM SALT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN C FOS; PROTEIN C JUN; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REINIOSIDE C; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; SAPONIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; POLYGALA; POLYGALA FALLAX; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; NF-KAPPA B; PHOSPHORYLATION; POLYGALA; RATS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPONINS; TRANSCRIPTION FACTOR AP-1;

EID: 84908253339     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.4556     Document Type: Article

References (23)

1. Bai YP, Hu CP, Chen MF, Xu KP, Tan GS, Shi RZ, Li YJ, Zhang GG (2009) Inhibitory effect of reinioside C on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via inhibiting NADPH oxidase/ROS/NF-kappaB pathway. Naunyn Schmiedebergs Arch Pharmacol 380: 399-406.
2. Bennett MR, Evan GI, Newby AC (1994) Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res 74: 525-536.
3. Blanc A, Pandey NR, Srivastava AK (2003) Synchronous activation of ERK 1/2, p38 MAPK and PKB/Akt signaling by H2 O2 in vascular smooth muscle cells: potential involvement in vascular disease. Int J Mol Med 11: 229-234.
4. Cain ML, Hester RL, Izevbigie EB (2006) Ethanol abrogates angiotensin II-stimulated vascular smooth muscle cell growth. Med Sci Monit 12: 162-168.
5. Chakraborti S, Chakraborti T (1998) Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell Signal 10: 675-683.
6. Dhar A, Young MR, Colburn NH (2002) The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235: 185-193.
7. Frank GD, Eguchi S (2003) Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II. Antioxid Redox Signal 5: 771-780.
8. Goode GK, Miller JP, HeagertyAM(1995) Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 345: 362-364.
9. Heeneman S, Sluimer JC, Daemen MJ (2007) Angiotensin-converting enzyme and vascular remodeling. Circ Res 101: 441-454.
10. Hessler JR, Robertson AL, Chisolm GM (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213-229.
11. Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH (2004) Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 61: 159-168.
12. Han C, Liu J, Liu X, Li M (2010) Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis 212: 206-212.
13. Li H,Wang QJ, Zhu DN, Yang Y (2008) Reinioside C, a triterpene saponin of Polygala aureocauda Dunn, exerts hypolipidemic effect on hyperlipidemic mice. Phytother Res 22: 159-164.
14. Li M, Fukagawa NK (2010) Age-related changes in redox signaling and VSMC function. Antioxid Redox Signal 12: 641-55.
15. Li PG, Xu JW, Ikeda K, Kobayakawa A, Kayano Y, Mitani T, Ikami T, Yamori Y (2005) Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 28: 369-377.
16. Paravicini TM, Touyz RM (2006) Redox signaling in hypertension. Cardiovasc Res 71: 247-258.
17. Rudijanto A (2007) The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 39: 86-93.
18. Satoh K, Nigro P, Berk BC (2010) Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12: 675-682.
19. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78: 539-552.
20. Touyz RM, Briones AM (2011) Reactive oxygen species and vascular biology: implications in human hypertension. Hypertens Res 34: 5-14.
21. Weiss D, Sorescu D, Taylor WR (2001) Angiotensin II and atherosclerosis. Am J Cardiol 87: 25C-32C.
22. Xu KP, HuangW, Tan GS (2006) Study on the antihyperlipidemia effective constituent of Polygala fallax Hemsl. Zhong Yao Cai 29:16-18.
23. Zhang GG, Bai YP, Chen MF, Shi RZ, Jiang DJ, Fu QM, Tan GS, Li YJ (2008) Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol 48: 115-121.